Robotic Pills for Gastrointestinal-Tract-Targeted Oral mRNA Delivery

Internal Auto-injecting Pill Poses New Mechanism of Administration

Region:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

*** 

So many Americans want to put mRNA out of their minds after the COVID-19 vaccine debacle. Dreams of injections gone bad with side effects including heart attacks, strokes, blood clots, and nerve damage have so many people around the world fearful of the next technological step. On cue with a bad dream Tao and coworkers from Harvard published on a “mechanical pill” to directly inject the stomach lining. If this was a sci-fi movie, people would be heading for the exits!

The authors summarize the technology in this key figure. In a nutshell, a pill would be swallowed and the devices would orient to the wall of the stomach or intestine (which would be difficult to control) and then the payload (mRNA) would be injected into the gastrointestinal epithelium and submucosa. The rich blood supply would immediately take the products into the blood stream. From there, the portal circulation would take blood to the liver via the hepatic portal vein. No one knows what a direct shot of mRNA would do to the liver. I can tell you as a doctor, I would be very concerned this could lead to even bigger complications than injection in the arm. Let’s hope this remains a bad dream for now.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Source

Wei Tao, Nicholas A. Peppas, Robotic pills for gastrointestinal-tract-targeted oral mRNA delivery, Matter, Volume 5, Issue 3, 2022, Pages 775-777, ISSN 2590-2385, https://doi.org/10.1016/j.matt.2022.02.008. (https://www.sciencedirect.com/science/article/pii/S25


Articles by: Dr. Peter McCullough

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]